Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

"Dread shed" is common with minoxidil but less so with other hair loss treatments.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

Dutasteride mesotherapy can cause hair loss in some people.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

The new gel with Zinc Oxide nanoparticles and finasteride shows promise for treating hair loss when applied to the skin.

New hair loss treatments show promise, but more research is needed to confirm their effectiveness.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

PRP is more effective than minoxidil and placebo for treating hair loss.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Dutasteride helps increase hair density in patients with female-pattern hair loss by activating a new growth mechanism.

Topical finasteride promotes hair growth with minimal side effects but needs more research for women and optimal use.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Hair health is affected by various conditions and requires personalized treatment.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

The study concluded that combination therapy with topical corticosteroids and hydroxychloroquine or finasteride is effective in treating Frontal fibrosing alopecia in Asians.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Dutasteride may become the top choice for treating hair loss.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Multiple treatments work best for hair loss.